NASDAQ
Jasper Therapeutics, Inc. (JSPR) has a free cash flow growth of 33.47% as of Friday, May 29, 2026. This represents a 1065.47% increase compared to its 12-month average of -3.47%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.